Načítá se...
Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure
BACKGROUND: Incident heart failure (HF) is increased in persons with human immunodeficiency virus (PHIV). Protease inhibitors (PIs) are associated with adverse cardiac remodeling and vascular events; however, there are no data on the use of PIs in PHIV with HF. OBJECTIVES: This study sought to compa...
Uloženo v:
| Vydáno v: | J Am Coll Cardiol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6202063/ https://ncbi.nlm.nih.gov/pubmed/30049313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2018.04.083 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|